Alkalinization
Analgesics..
Antiandrogens..
Bromhexine
Budesonide
Cannabidiol
Colchicine
Conv. Plasma
Curcumin
Ensovibep
Famotidine
Favipiravir
Fluvoxamine
Hydroxychlor..
Iota-carragee..
Ivermectin
Lactoferrin
Lifestyle..
Melatonin
Metformin
Molnupiravir
Monoclonals..
Nigella Sativa
Nitazoxanide
Nitric Oxide
Paxlovid
Peg.. Lambda
Povidone-Iod..
Quercetin
Remdesivir
Vitamins..
Zinc

Other
Feedback
Home
Home   COVID-19 treatment studies for Hydroxychloroquine  COVID-19 treatment studies for HCQ  C19 studies: HCQ  HCQ   Select treatmentSelect treatmentTreatmentsTreatments
Alkalinization Meta Lactoferrin Meta
Melatonin Meta
Bromhexine Meta Metformin Meta
Budesonide Meta Molnupiravir Meta
Cannabidiol Meta
Colchicine Meta Nigella Sativa Meta
Conv. Plasma Meta Nitazoxanide Meta
Curcumin Meta Nitric Oxide Meta
Ensovibep Meta Paxlovid Meta
Famotidine Meta Peg.. Lambda Meta
Favipiravir Meta Povidone-Iod.. Meta
Fluvoxamine Meta Quercetin Meta
Hydroxychlor.. Meta Remdesivir Meta
Iota-carragee.. Meta
Ivermectin Meta Zinc Meta

Other Treatments Global Adoption
All Studies   Meta Analysis   Recent:  
0 0.5 1 1.5 2+ Hospitalization time 33% Improvement Relative Risk c19hcq.org Ashinyo et al. HCQ for COVID-19 LATE TREATMENT Is late treatment with HCQ beneficial for COVID-19? Retrospective 307 patients in Ghana Shorter hospitalization with HCQ (p=0.029) Ashinyo et al., Pan African Medical J., 37:1, doi:10.11604/pamj.supp.2020.37.1.25718 Favors HCQ Favors control
Clinical characteristics, treatment regimen and duration of hospitalization among COVID-19 patients in Ghana: a retrospective cohort study
Ashinyo et al., Pan African Medical Journal, 37:1, doi:10.11604/pamj.supp.2020.37.1.25718
Ashinyo et al., Clinical characteristics, treatment regimen and duration of hospitalization among COVID-19 patients in Ghana:.., Pan African Medical Journal, 37:1, doi:10.11604/pamj.supp.2020.37.1.25718
Sep 2020   Source   PDF  
  Twitter
  Facebook
Share
  All Studies   Meta
Retrospective 307 hospital patients in Ghana showing 33% reduction in hospitalization time with HCQ, 29% reduction with HCQ+AZ, and 37% reduction with CQ+AZ.
hospitalization time, 33.0% lower, relative time 0.67, p = 0.03, treatment 61, control 61.
Effect extraction follows pre-specified rules prioritizing more serious outcomes. Submit updates
Ashinyo et al., 15 Sep 2020, retrospective, Ghana, peer-reviewed, 16 authors.
All Studies   Meta Analysis   Submit Updates or Corrections
This PaperHCQAll
Abstract: Supplement Research Clinical characteristics, treatment regimen and duration of hospitalization among COVID-19 patients in Ghana: a retrospective cohort study Mary Eyram Ashinyo, Vida Duti, Stephen Dajaan Dubik, Kingsley Ebenezer Amegah, Selorm Kutsoati, Ebenezer OduroMensah, Peter Puplampu, Martha Gyansa-Lutterodt, Delese Mimi Darko, Kwame Ohene Buabeng, Anthony Ashinyo, Anthony Adofo Ofosu, Nyonuku Akosua Baddoo, Samuel Kaba Akoriyea, Francis Ofei, Patrick Kuma-Aboagye Corresponding author: Mary Eyram Ashinyo, Institutional Care Division, Ghana Health Service Headquarters, Private Mail Bag, Accra, Ghana. mary.ashinyo@ghsmail.org Received: 23 Aug 2020 - Accepted: 10 Sep 2020 - Published: 15 Sep 2020 Keywords: COVID-19, clinical characteristics, azithromycin, chloroquine, hydroxychloroquine, supportive treatment, duration of hospitalization, infectious diseases, Ghana Copyright: Mary Eyram Ashinyo et al. Pan African Medical Journal (ISSN: 1937-8688). This is an Open Access article distributed under the terms of the Creative Commons Attribution International 4.0 License (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. Cite this article: Mary Eyram Ashinyo et al. Clinical characteristics, treatment regimen and duration of hospitalization among COVID-19 patients in Ghana: a retrospective cohort study. Pan African Medical Journal. 2020;37(1):9. 10.11604/pamj.supp.2020.37.1.25718 Available online at: https://www.panafrican-med-journal.com/content/series/37/1/9/full This article is published as part of the supplement: PAMJ Special issue on COVID 19 in Africa (Volume 2) sponsored by the The Pan African Medical Journal. Available online at https://www.panafrican-med-journal.com//content/series/1/ Clinical characteristics, treatment regimen and duration of hospitalization among COVID-19 patients in Ghana: a retrospective cohort study 1,& 2 Mary Eyram Ashinyo , Vida Duti , Stephen Dajaan Dubik3, Kingsley Ebenezer Amegah4, Selorm Kutsoati5, Ebenezer Oduro-Mensah6, Peter Puplampu7, Martha Gyansa-Lutterodt8, Delese Mimi Darko9, Kwame Ohene Buabeng10, Anthony Ashinyo11, Anthony Adofo Ofosu12, Nyonuku Akosua Baddoo13, Samuel Kaba Akoriyea1, Francis Ofei14, Patrick Kuma-Aboagye15 1 Institutional Care Division, Ghana Health Service Headquarters, Private Mail Bag, Accra, Ghana, 2IRCGhana, Cantoments-Accra, Ghana, 3School of Allied Health Sciences, University for Development Studies, Tamale, Ghana, 4Department of Health Information, Hohoe Municipal Hospital, Hohoe, Mary Eyram Ashinyo et al. PAMJ - 37(Supp 1):9. 15 Sep 2020. - Page numbers not for citation purposes. 1 Supplement Ghana, 5Ga East Municipal Health Directorate, Accra, Ghana, 6Ga East Municipal Hospital, Accra, Ghana, 7Department of Medicine, Korle Bu Teaching Hospital, Accra, Ghana, 8Technical Coordination Directorate, Ministry of Health, Accra, Ghana, 9Food and Drug Authority, Accra, Ghana, 10 Department of Pharmacy Practice, Kwame Nkrumah University of Science and Technology, Ghana, 11National AIDS/STI Control Programme, Accra, Ghana, 12Ghana Health Service, Accra, Ghana, 13National AIDS/STI Control Programme, Ghana Health Service, Accra, Ghana, 14Department of Medicines, School of Medicine and Dentistry, University of Cape Coast, 15Office of the Director General, Ghana Health Service Headquarters, Accra, Ghana & Corresponding author Mary Eyram Ashinyo,..
Late treatment
is less effective
Please send us corrections, updates, or comments. Vaccines and treatments are complementary. All practical, effective, and safe means should be used based on risk/benefit analysis. No treatment, vaccine, or intervention is 100% available and effective for all current and future variants. We do not provide medical advice. Before taking any medication, consult a qualified physician who can provide personalized advice and details of risks and benefits based on your medical history and situation. FLCCC and WCH provide treatment protocols.
  or use drag and drop   
Submit